Navigation Links
New Leadership Elected to the American Society of Hematology
Date:11/4/2008

WASHINGTON, Nov. 3 /PRNewswire-USNewswire/ -- The American Society of Hematology (ASH), the world's largest professional society of blood specialists, welcomes five new officers to its Executive Committee, the governing body of the organization. The officers will begin serving their terms in January 2009.

J. Evan Sadler, MD, PhD, will serve a one-year term as vice president, followed by successive terms as president-elect and president. Charles Abrams, MD, will serve as secretary, and new councillors David M. Bodine, PhD, Elaine A. Muchmore, MD, and David A. Williams, MD, will serve four-year terms. These individuals are well-respected hematologists and active members of the Society.

In addition to having been a long time Associate Editor of Blood, Dr. Sadler has previously been a member of the Executive Committee. He served as a councillor from 1998-2002, and as treasurer from 2003-2006. Most recently he has served as co-chair of the Committee on Investment and Audit. Dr. Sadler is currently Professor of Medicine, Hematology Division, Professor of Biochemistry and Molecular Biophysics, and Co-Director of the Hematology-Oncology Fellowship Program at the Washington University School of Medicine in St. Louis, Missouri.

Dr. Abrams currently serves on the Publications Committee and the Small CME Meetings Subcommittee, and is on the Editorial Boards of both Blood and The Hematologist. He is an Associate Professor at the University of Pennsylvania School of Medicine, Chair of the American Board of Internal Medicine Hematology Board, Co-Chair of the NIH Scientific Review Committee on Hemostasis and Thrombosis, and Scientific Director of the Blood Center at Penn/CHOP (under development).

Dr. Bodine serves on the Journals Committee and has been active with ASH for a number of years. Dr. Bodine is Chief of the Genetics and Molecular Biology Branch (GMBB) and Chief of the Hematopoiesis Section of the GMBB at the National Institute for Human Genome Research, Division of Intramural Research, National Institutes of Health.

Dr. Muchmore currently serves on the Committee on Training Programs, and also as ASH representative to the Association of Subspecialty Professors. She is currently Professor of Medicine, Division of Hematology/Oncology, at the University of California -- San Diego, represents ASH at the Council of Academic Specialties, and is co-editor of Hematology 2008.

Currently serving on the Committee on Communications, Dr. Williams has also served on a number of other committees in his tenure at ASH. He is Chief, Hematology/Oncology, Department of Medicine and Director of Translational Research at Children's Hospital Boston, Fikes Professor of Pediatrics at Harvard Medical School, and Director, Pediatric Hematology/Oncology Fellowship Program at Children's Hospital Boston and the Dana-Farber Cancer Institute.

The American Society of Hematology (http://www.hematology.org) is the world's largest professional society concerned with the causes and treatment of blood disorders. Its mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting blood, bone marrow, and the immunologic, hemostatic, and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology.


'/>"/>
SOURCE American Society of Hematology
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Meijer Honored by Michigan Primary Care Association for Leadership in Promoting Health of Michigan Residents
2. Capital BlueCross Formalizes Leadership Team; Elects Lehr President and CEO
3. Schering-Plough Announces Transition of Animal Health Leadership
4. Perth Leadership Institute Issues Alert on the Post-Crash Environment Facing HR/Leadership Development
5. ALS Patients and Researchers Unite in Boston for 4th Annual Leadership Summit
6. Underwriters Laboratories to Host Global Leadership Conference on Fire and Life Safety
7. Lumension Security Receives Frost & Sullivan 2008 Global Market Penetration Leadership Award
8. Pacira Pharmaceuticals, Inc. Adds Experienced CFO James S. Scibetta to Leadership of the Organization
9. Higher Number of HIV Infections Must Translate Into Leadership & Action by U.S. Government
10. Extend Health, Inc. Adds Veteran Leadership to Management Team
11. Mariners Inn Announces New Executive Leadership
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... ... June 23, 2017 , ... ... Conference from Sept. 18 to 20. , The two-day conference is focused on ... the goal of improving patients’ lives and eliminating racial breast cancer-related disparities. The ...
(Date:6/23/2017)... ... , ... Ross Insurance Agency ( http://www.rossinsuranceagency.com ) saves clients ... (FEMA) recent update of flood zones, more people than ever are in flood ... to reflect the actual risk in flood zone areas during a time when ...
(Date:6/23/2017)... ... June 23, 2017 , ... Jusino Insurance Services, ... communities in the greater Chicago metropolitan area, is embarking on a charity drive ... in Chicago. , Founded in 1897, Hephzibah Children’s Association is one of the ...
(Date:6/22/2017)... FL (PRWEB) , ... June 22, 2017 , ... Branches, ... received more than $245,000 in grant funding to support its programs focused on providing ... Branches, Inc. was awarded a grant by the Foundation of $15,000 to support its ...
(Date:6/22/2017)... ... June 22, 2017 , ... Children’s National Health System ... (AHA) to launch a Rheumatic Heart Disease Center, with the goal of developing ... heart disease (RHD) in high-risk, financially disadvantaged countries and low-income communities across the ...
Breaking Medicine News(10 mins):
(Date:6/14/2017)... The Bio Supply Management Alliance (BSMA) has ... and the Biomedical Manufacturing Network to advance ... California by providing a platform for ... workforce development. The primary focus of this alliance is ... well as small and mid-sized biomedical companies. ...
(Date:6/13/2017)... , June 13, 2017 Zimmer Biomet Holdings, ... healthcare, today announced that the U.S. Food and Drug Administration ... June 3, 2015 relating to its Zhejiang, China ... "The successful clearance of the Warning ... manufacturing facility is a measure of the progress we ...
(Date:6/11/2017)... , June 10, 2017  Eli Lilly and Company ... from three Phase 3 studies of galcanezumab, an investigational ... including late-breaking data on several key secondary endpoints for ... results from these studies (EVOLVE-1, EVOLVE-2 and REGAIN) will ... annual scientific meeting in Boston . ...
Breaking Medicine Technology: